










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://52.214.119.220/wiki/index.php?action=history&amp;feed=atom&amp;title=Conformation-specific_anti-Factor_IX_antibodies</id>
		<title>Conformation-specific anti-Factor IX antibodies - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://52.214.119.220/wiki/index.php?action=history&amp;feed=atom&amp;title=Conformation-specific_anti-Factor_IX_antibodies"/>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Conformation-specific_anti-Factor_IX_antibodies&amp;action=history"/>
		<updated>2026-04-16T08:05:59Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.11.2</generator>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Conformation-specific_anti-Factor_IX_antibodies&amp;diff=1129374&amp;oldid=prev</id>
		<title>David Canner at 15:25, 1 October 2010</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Conformation-specific_anti-Factor_IX_antibodies&amp;diff=1129374&amp;oldid=prev"/>
				<updated>2010-10-01T15:25:36Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 15:25, 1 October 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of the complex of the 10C12 Fab and Factor IX-(1-47)&amp;lt;ref&amp;gt;PMID:14722079&amp;lt;/ref&amp;gt;. A ribbon diagram depicts the Fab fragment of the antibody 10C12. Light chain is shown in light blue, and heavy chain is shown in dark blue. Factor IX-(1-47) is also shown as a ribbon diagram, colored blue to yellow from the N terminus to the C terminus. Six calcium ions are shown from Ca-1 to Ca-7. Ca-6 is not present in this structure. Residues 1, 5, 6, 9, 11, and 45 in Factor IX-(1-47) are labeled. The side chains of residues 5, 6, 9, and 11 are included.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Crystal structure of the complex of the 10C12 Fab and Factor IX-(1-47)&amp;lt;ref&amp;gt;PMID:14722079&amp;lt;/ref&amp;gt;. A ribbon diagram depicts the Fab fragment of the antibody 10C12. Light chain is shown in light blue, and heavy chain is shown in dark blue. Factor IX-(1-47) is also shown as a ribbon diagram, colored blue to yellow from the N terminus to the C terminus. Six calcium ions are shown from Ca-1 to Ca-7. Ca-6 is not present in this structure. Residues 1, 5, 6, 9, 11, and 45 in Factor IX-(1-47) are labeled. The side chains of residues 5, 6, 9, and 11 are included.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==Additional Resources==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;For additional information, see: [[Hemophilia]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;br /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>David Canner</name></author>	</entry>

	<entry>
		<id>http://52.214.119.220/wiki/index.php?title=Conformation-specific_anti-Factor_IX_antibodies&amp;diff=951226&amp;oldid=prev</id>
		<title>Nadia Dorochko: New page: Image:glaOmagaP3.jpg  Crystal structure of the complex of the 10C12 Fab and Factor IX-(1-47)&lt;ref&gt;PMID:14722079&lt;/ref&gt;. A ribbon diagram depicts the Fab fragment of the antibody 10C12. L...</title>
		<link rel="alternate" type="text/html" href="http://52.214.119.220/wiki/index.php?title=Conformation-specific_anti-Factor_IX_antibodies&amp;diff=951226&amp;oldid=prev"/>
				<updated>2009-04-26T23:23:26Z</updated>
		
		<summary type="html">&lt;p&gt;New page: &lt;a href=&quot;/wiki/index.php/Image:GlaOmagaP3.jpg&quot; title=&quot;Image:GlaOmagaP3.jpg&quot;&gt;Image:glaOmagaP3.jpg&lt;/a&gt;  Crystal structure of the complex of the 10C12 Fab and Factor IX-(1-47)&amp;lt;ref&amp;gt;PMID:14722079&amp;lt;/ref&amp;gt;. A ribbon diagram depicts the Fab fragment of the antibody 10C12. L...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Image:glaOmagaP3.jpg]]&lt;br /&gt;
&lt;br /&gt;
Crystal structure of the complex of the 10C12 Fab and Factor IX-(1-47)&amp;lt;ref&amp;gt;PMID:14722079&amp;lt;/ref&amp;gt;. A ribbon diagram depicts the Fab fragment of the antibody 10C12. Light chain is shown in light blue, and heavy chain is shown in dark blue. Factor IX-(1-47) is also shown as a ribbon diagram, colored blue to yellow from the N terminus to the C terminus. Six calcium ions are shown from Ca-1 to Ca-7. Ca-6 is not present in this structure. Residues 1, 5, 6, 9, 11, and 45 in Factor IX-(1-47) are labeled. The side chains of residues 5, 6, 9, and 11 are included.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Nadia Dorochko</name></author>	</entry>

	</feed>